Edition:
United Kingdom

OPKO Health Inc (OPK.OQ)

OPK.OQ on NASDAQ Stock Exchange Global Select Market

3.65USD
23 May 2018
Change (% chg)

$-0.10 (-2.67%)
Prev Close
$3.75
Open
$3.70
Day's High
$3.86
Day's Low
$3.63
Volume
1,195,966
Avg. Vol
1,181,946
52-wk High
$7.25
52-wk Low
$2.66

Chart for

About

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in... (more)

Overall

Beta: 1.68
Market Cap(Mil.): $2,098.03
Shares Outstanding(Mil.): 559.47
Dividend: --
Yield (%): --

Financials

  OPK.OQ Industry Sector
P/E (TTM): -- 28.66 32.90
EPS (TTM): -0.43 -- --
ROI: -9.41 13.20 12.74
ROE: -12.14 14.95 14.64

BRIEF-Opko Health Reports Q1 Loss Per Share Of $0.08

* Q1 REVENUE $254.9 MILLION VERSUS I/B/E/S VIEW $236.9 MILLION

08 May 2018

BRIEF-OPKO Health Inc Says Intends To Remain On Tel Aviv Stock Exchange

* OPKO HEALTH INC - INTENDS TO REMAIN ON TEL AVIV STOCK EXCHANGE AND WITHDRAW ITS REQUEST TO VOLUNTARILY DELIST ITS COMMON STOCK FROM TASE

27 Apr 2018

BRIEF-Opko Health Says Board Resolved To Voluntary Delist Common Stock From Tel Aviv Stock Exchange SEC Filing

* OPKO HEALTH SAYS BOARD RESOLVED TO VOLUNTARY DELIST COMMON STOCK FROM TEL AVIV STOCK EXCHANGE - SEC FILING Source text: (https://bit.ly/2v5nNYg) Further company coverage:

09 Apr 2018

BRIEF-OPKO Health Qtrly Diluted Loss Per Share $0.38

* OPKO HEALTH REPORTS 2017 FOURTH QUARTER BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS

01 Mar 2018

Earnings vs. Estimates